Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Microenvironments in Tuberculous Granulomas Are Delineated by Distinct Populations of Macrophage Subsets and Expression of Nitric Oxide Synthase and Arginase Isoforms

Joshua T. Mattila, Olabisi O. Ojo, Diane Kepka-Lenhart, Simeone Marino, Jin Hee Kim, Seok Yong Eum, Laura E. Via, Clifton E. Barry III, Edwin Klein, Denise E. Kirschner, Sidney M. Morris Jr., Philana Ling Lin and JoAnne L. Flynn
J Immunol July 15, 2013, 191 (2) 773-784; DOI: https://doi.org/10.4049/jimmunol.1300113
Joshua T. Mattila
*Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15261;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olabisi O. Ojo
*Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15261;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diane Kepka-Lenhart
*Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15261;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simeone Marino
†Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin Hee Kim
‡National Masan Tuberculosis Hospital, Changwon 631-710, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seok Yong Eum
§International Tuberculosis Research Institute, Changwon 631-710, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura E. Via
¶Tuberculosis Research Section, Laboratory of Clinical Infectious Disease, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clifton E. Barry III
¶Tuberculosis Research Section, Laboratory of Clinical Infectious Disease, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edwin Klein
‖Division of Laboratory Animal Resources, University of Pittsburgh, Pittsburgh PA 15261;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denise E. Kirschner
†Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sidney M. Morris Jr.
*Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15261;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philana Ling Lin
#Department of Pediatrics, Children’s Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh PA 15224; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JoAnne L. Flynn
*Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15261;
**Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF
Loading

Abstract

Macrophages in granulomas are both antimycobacterial effector and host cell for Mycobacterium tuberculosis, yet basic aspects of macrophage diversity and function within the complex structures of granulomas remain poorly understood. To address this, we examined myeloid cell phenotypes and expression of enzymes correlated with host defense in macaque and human granulomas. Macaque granulomas had upregulated inducible and endothelial NO synthase (iNOS and eNOS) and arginase (Arg1 and Arg2) expression and enzyme activity compared with nongranulomatous tissue. Immunohistochemical analysis indicated macrophages adjacent to uninvolved normal tissue were more likely to express CD163, whereas epithelioid macrophages in regions where bacteria reside strongly expressed CD11c, CD68, and HAM56. Calprotectin-positive neutrophils were abundant in regions adjacent to caseum. iNOS, eNOS, Arg1, and Arg2 proteins were identified in macrophages and localized similarly in granulomas across species, with greater eNOS expression and ratio of iNOS/Arg1 expression in epithelioid macrophages as compared with cells in the lymphocyte cuff. iNOS, Arg1, and Arg2 expression in neutrophils was also identified. The combination of phenotypic and functional markers support that macrophages with anti-inflammatory phenotypes localized to outer regions of granulomas, whereas the inner regions were more likely to contain macrophages with proinflammatory, presumably bactericidal, phenotypes. Together, these data support the concept that granulomas have organized microenvironments that balance antimicrobial anti-inflammatory responses to limit pathology in the lungs.

Introduction

The initial immunologic events following Mycobacterium tuberculosis infection include cytokine- and chemokine-mediated recruitment of monocytes, neutrophils, and tissue-resident macrophages (1). Macrophages alone are not sufficient to control intracellular replication in the majority of cases but must interact with activated T cells (2). The product of these interactions is the granuloma, an organized structure rich in macrophages and lymphocytes that acts as a functional unit for controlling M. tuberculosis infection. The presence of granulomas is not necessarily indicative of controlled M. tuberculosis infection because hosts with active tuberculosis (TB) have numerous granulomas, but the fact that most M. tuberculosis–infected individuals never experience active disease (1) suggests that granulomas in immunologically competent individuals can be highly effective at restraining bacterial growth and dissemination.

The necrotic (caseous) granuloma is the most common lesion associated with active TB. Necrotic granulomas have an outer lymphocyte cuff dominated by T and B cells and a macrophage-rich middle region that surrounds an amorphous center of caseous necrosis. Other types of granulomas include completely cellular, nonnecrotic granulomas and suppurative granulomas (heavily infiltrated by neutrophils) (3). In experimentally infected cynomolgus macaques, caseous granulomas form by 4–6 wk postinfection (4, 5), whereas nonnecrotic granulomas are not observed until later and primarily during active or reactivated disease (5). Partially mineralized and highly fibrotic (fibrocalcific) granulomas are associated with clinically latent infection but can also be found in active TB. Other granuloma types, including caseous granulomas, can be present in latent infection as well, indicating that the types of granulomas that are present incompletely describe the infection status of the host. This being said, latent M. tuberculosis infection is associated with lower numbers of granulomas than active TB (5).

The high level of stratification in human and nonhuman primate granulomas (3, 6) suggests that protection depends on microenvironments (7, 8) that promote bacterial clearance while minimizing damage to uninvolved tissues adjacent to the granuloma. Macrophage subsets engaging in anti-inflammatory or proinflammatory processes are likely to be important, yet poorly understood, mediators determining the characteristics of these microenvironments. Activated macrophages are often classified as either classically activated M1 (proinflammatory) macrophages that engage in bactericidal activity or alternatively activated M2 (anti-inflammatory) macrophages that mediate prohealing responses. Expression of inducible NO synthase (iNOS) is the hallmark of proinflammatory macrophages and, in murine systems, is necessary for improved resistance to TB (9–11). iNOS-expressing macrophages have been identified in the lungs of humans with TB (12–14), although a correlation between human TB and deficient iNOS expression has proven difficult (15). The other NOS isoforms, endothelial NOS (eNOS) and neural NOS (nNOS), can also be present in granulomas (12), but it is not known whether they have homeostatic or bactericidal functions.

Prohealing anti-inflammatory macrophages are characterized by arginase 1 (Arg1) expression (16, 17), although this is best defined in murine systems. Arginases can compete with NO synthases for l-arginine and generate urea and l-ornithine, which can be subsequently converted to l-proline (18), an amino acid used in collagen synthesis and wound healing (19, 20), or to polyamines (18), which can play a variety of roles in cell physiology and pathophysiology (21). Although anti-inflammatory macrophages have important functions in healing and antihelminth responses (22), arginase expression can diminish protection against intracellular pathogens, including M. tuberculosis (23, 24). Macrophage arginase expression has been identified in tuberculous lung from humans (25) and also in PBMCs of patients infected with M. tuberculosis (26), but the contribution of arginase to protective or pathologic responses in M. tuberculosis infection in humans remains undetermined. The NOS/arginase paradigm of macrophage activation is best defined for mice, however, and the signals in primates that drive macrophage activation remain largely undefined. Considering this, it is likely that macrophage polarization occurs on a spectrum (27) with classical and alternative activation on opposing ends of a spectrum but with most macrophages having characteristics somewhere along that continuum.

We examined granulomas from cynomolgus macaques with active or clinically latent M. tuberculosis infection to determine whether specific populations of macrophage localize to specific microenvironments in different granuloma types. Moreover, because NOS and arginase expression may mediate antimycobacterial activity and immunopathology, we sought to identify how NOS and arginase expression relates to the distribution of microenvironment-specific macrophage populations. Studies using mathematical modeling have suggested that granulomas are organized in a nonrandom fashion, and chemokine and cytokine gradients also exist, helping to establish cell patterns (28). We present biochemical, molecular, and immunohistochemical evidence demonstrating that macrophages and neutrophils in macaque granulomas can express functional NOS and arginase enzymes and are organized into different microenvironments. Furthermore, we identified similarities in macrophage distribution and NOS and arginase expression between macaque and human granulomas, suggesting these functions are conserved across primate species. These results provide new data on the diversity of macrophages and neutrophils in granulomas and their effector capacity and thus may lead to an improved understanding of the mechanisms underlying antimycobacterial responses.

Materials and Methods

Tissue processing and sectioning

All animal procedures and husbandry practices were included in protocols approved by the University of Pittsburgh’s Institutional Animal Use and Care Committee. Cynomolgus macaques were infected with low-dose (∼25 CFU) Erdman-strain M. tuberculosis as previously described (4). Macaques with active TB were humanely euthanized and necropsied as previously described (4, 5). All samples obtained were from animals undergoing necropsy as part of other studies. For immunohistochemistry, granuloma-containing tissues were excised and fixed in 10% neutral buffered formalin prior to placement in histology cassettes and paraffin embedding. Tissues were cut into 5-μm–thick sections by the University of Pittsburgh Medical Center’s in situ histology laboratory and mounted on SuperFrost Plus slides (Thermo Fisher Scientific, Waltham, MA). Formalin-fixed paraffin-embedded human lung tissue samples containing granulomas were dissected from tissue removed during therapeutic lung resection surgery at the National Masan Tuberculosis Hospital from patients refractory to second line drug therapy. Tissue collection (2003–2007) was approved by the National Masan Tuberculosis Hospital institutional review board, an exemption from National Institutes of Health, and with written consent of the subjects; samples were deidentified when provided for analysis.

Immunofluorescence, immunohistochemistry, imaging, and image analysis

Formalin-fixed paraffin-embedded tissue sections from M. tuberculosis–infected macaques m907, m9209 m1307, m1707, m3809, m9905, m10708, m21802, m15304, and m13207 were selected for study. All animals except m10708 had active TB at the time of necropsy. Tissue sections were deparaffinized in xylene, 100% ethanol, and 95% ethanol. Tissue sections were then placed into an Ag retrieval buffer (20 mM Tris/820 μM EDTA/0.00005% Tween 20 [pH 9]) containing a pressure cooker (Manttra, Piscataway, NJ), incubated under pressure for 7 min before removal from the hotplate, and allowed to cool slowly over 30 min. Sections were incubated in blocking buffer (2.5% BSA in PBS) for 30 min at 37°C, prior to addition of primary Ab diluted in blocking buffer. Abs for immunohistochemistry were against human CD3ε (ready-to-use format, 1:2 dilution; DakoCytomation, Carpintera, CA), CD11c (clone 5D11, 1:30 dilution; Leica Microsystems, Buffalo Grove, IL), CD68 (clone KP1, 1:50 dilution; Lab Vision, San Diego, CA), CD163 (clone 10D6, 1:30 dilution; Lab Vision), calprotectin (clone MAC387; 1:100 dilution; Lab Vision), HAM56 (ready-to-use format, 1:2 dilution; Enzo Life Sciences, Farmingdale, NY), iNOS (rabbit polyclonal; Lab Vision), eNOS (rabbit polyclonal; Lab Vision), Arg1 (clone 19/arginase1, 1:100 dilution; BD Biosciences), arginase 2 (rabbit polyclonal, 1:40 dilution; Santa Cruz Biotechnology, Santa Cruz, CA), and nitrotyrosine (rabbit polyclonal, 1:100 dilution; Millipore, Billerica, MA). The specificity of iNOS and eNOS Abs were confirmed by Western blotting of iNOS and eNOS (0.1 μg/lane) in conjunction with 1 μg M. tuberculosis lysate to confirm that the Abs were isoform specific and not reactive with bacterial proteins (data not shown). We were unable to identify an anti-nNOS Ab that worked for immunohistochemistry in macaque tissues and was not cross-reactive with other NOS isoforms (data not shown). Tissue sections were incubated at room temperature in cocktails of primary Abs for 1 h. Secondary Abs, purchased from either Jackson ImmunoResearch Laboratories (West Grove, PA) or Life Technologies, were diluted in blocking buffer and applied to tissue sections that had been washed three to five times with IHC wash buffer (0.2% Tween-20 in PBS) and incubated for 1 h at room temp in the dark. HAM56 was stained with an anti-mouse μ-chain–specific secondary Ab (Jackson ImmunoResearch Laboratories) that was made in donkey and not crossreactive with mouse IgG Abs. The specificity of secondary Abs was confirmed either by isotype or no-primary controls using the same staining and imaging protocol as sections containing stained with primary Abs. The slides were then washed three to five times with IHC buffer and directly labeled conjugates applied. Abs for direct labeling were chosen based on their ability to work well following significant dilution when used with a secondary Ab. The unlabeled Abs were labeled with either Alexa Fluor 488 or Alexa Fluor 647 using the Zenon direct labeling kit (Life Technologies). Tissue sections were incubated with direct conjugates for 2 h at room temperature or overnight at 4°C. Slides were washed four times with IHC wash buffer, once with PBS, and then coverslips were applied using Prolong Gold mounting medium containing DAPI (Life Technologies). Slides were cured for 24 h at room temperature before imaging. Granulomas were imaged with either an Olympus Fluoview 500 or Fluoview 1000 laser scanning confocal microscope (Olympus, Center Valley, PA) maintained by the University of Pittsburgh’s Center for Biologic Imaging and a Fluoview 1000 laser scanning confocal microscope maintained by the University of Pittsburgh’s Microbiology and Molecular Genetics Department. Individual tissue sections from animals with active TB frequently contained multiple granulomas of various sizes and type; we chose to image granulomas with features that were representative of that particular granuloma type. Three-color images (red, green, and far red [pseudocolored as blue]) were acquired sequentially, followed by a DAPI image (gray) showing nuclei. Images (either single sections or serial Z sections acquired at 1-μm intervals) were acquired and saved as TIFF-format images. Z series images were opened with MacBiophotonics ImageJ (available at www.macbiophotonics.ca/software.htm) or FIJI (available at http://pacific.mpi-cbg.de/wiki/index.php/Downloads) and saved as maximum-intensity projections. At least three fields in the macrophage–lymphocyte region were imaged at ×400–600 original magnification for counting cells in tissues. Images were opened in Photoshop CS4 (Adobe Systems, San Jose CA), overlaid with a grid to facilitate analysis, and counted manually by examining each channel separately or in combination for positively stained cells. The number of nuclei per image, which was used to determine the number of cells within an image, was assessed with CellProfiler v2.0 (available at http://www.cellprofiler.org/). Granulomas were too large to be imaged by one ×200 original magnification field; consequently, multiple overlapping fields were acquired and the image of the entire granuloma assembled into a single montage using Photoshop (Adobe Systems). Preliminary work indicated that counting individual cells in granulomas for phenotypic analysis by automated or manual means was not going to be feasible due to the complexity of the environment; consequently, we used a region-based approach to analyze staining (signal) intensity in lymphocyte cuff or epithelioid macrophage regions. For analysis of region-based characteristics (macrophage markers, iNOS/Arg1 expression), nonoverlapping image fields (×200 original magnification) of granulomas containing both epithelioid macrophage and lymphocyte cuff regions were acquired as previously indicated. From these images, regions of interest were drawn around epithelioid macrophage or lymphocyte cuff regions, and the mean pixel intensity of the red, green, and blue channels was determined with Photoshop’s histogram tool (Adobe Systems). The iNOS/Arg1 ratio was calculated by dividing the mean iNOS signal by the mean Arg1 signal. Pairwise comparisons were made between macrophage surface marker signal or iNOS/Arg1 signal ratio were made between the epithelioid macrophage and lymphocyte cuff regions.

Auramine-rhodamine staining

Granulomas were stained with auramine-rhodamine reagents to visualize the mycobacterial cell wall component mycolic acid. Tissue sections were deparaffinized as previously indicated and equilibrated in distilled H2O for 5 min before being stained with auramine-rhodamine for 30 min. Excess stain was washed off with distilled H2O and decolorized in multiple washes of isopropanol with 5% HCl (v/v) before being counterstained with potassium permanganate for 50 s. Slides were washed and air dried before imaging. All auramine-rhodamine staining reagents were purchased from BD Biosciences. Auramine-rhodamine–stained slides were imaged on an Olympus Provis epifluorescence microscope (Olympus) at ×200 original magnification. Following this, the immersion oil was removed in a xylene bath, and the slides were then stained with H&E using standard protocols. Coverslips were mounted on H&E-stained slides with Permount (Thermo Fisher Scientific), and the same tissue section used for the auramine-rhodamine staining was used to acquire the H&E image on the same microscope previously used to ensure consistent magnification and perspective. To determine the localization of M. tuberculosis or M. tuberculosis Ags in granulomas and colocalize them with cells, the red auramine-rhodamine image was overlaid on a grayscale image of the H&E-stained granuloma with Photoshop (Adobe Systems) and this position located on the color version of the H&E.

NOS and arginase activity assays

Granuloma-containing tissues for arginase assays that had been flash frozen in liquid nitrogen at necropsy and stored at −80°C were homogenized with a Medimachine tissue homogenizer (BD Biosciences) under BSL3 conditions. Tissues were homogenized in PBS containing 0.1% Triton X-100 and protease inhibitor mixture (Thermo Fisher Scientific) without EDTA and filtered through a 0.22-μm syringe filter. Protein concentrations were measured using a BCA Protein Assay Kit (Thermo Fisher Scientific) with BSA as a protein standard. Arginase or NOS activity were assayed under BSL2 conditions using filter-sterilized samples. Arginase activity was determined as previously described (29) by following the conversion of l-[guanidino-14C]arginine to [14C]urea, which was quantified by scintillation counting after its conversion to 14CO2 and trapping as Na214CO3. Tissues for NOS assays were from recently necropsied animals that had been homogenized (see below) and stored at −80°C until the time of assay. Initial attempts to quantify NOS activity in lung homogenates was done using the [3H]l-arginine to [3H]citrulline conversion-based assay but yielded unacceptable levels of background signal that was not inhibited by selective NOS or arginase inhibitors. Consequently, NOS activity was determined using a cell lysate–based assay that measured nitrite (NO2−) via the Griess reaction. Lung tissue was homogenized and lysed in 1–3 ml 25 mM Tris-HCl (pH 7.4) with 1 mM EDTA and 1 mM EGTA and filter sterilized by passing through a 0.22-μm syringe filter. Protein concentrations in tissue homogenates were measured by BCA protein assay (Thermo Fisher Scientific). NOS assays were performed by adding 10 μl tissue homogenate to 40 μl assay buffer (75 μM l-arginine, 1 mM NADPH, 0.25 μM calmodulin, 2.5 mM FAD, 2.5 mM FMN, 10 μM tetrahydrobiopterin, 440 μM nor-NOHA [Cayman Chemical Company, Ann Arbor, MI], 120 μM CaCl2, and 120 μM MgCl2 in 100 mM HEPES) followed by an overnight incubation at 37°C to ensure the reaction went to completion. A replicate control sample was prepared in the same buffer but included N6-​(1-​iminoethyl)-​l-​lysine (L-NIL; Cayman Chemical), a selective iNOS inhibitor. Recombinant nitrate reductase was added to the reaction to convert nitrate to nitrite and then the reaction assayed with freshly prepared Griess reagent (0.05% naphthylethylenediamine dihydrochloride and 0.5% sulfanilamide in 2.5% H3PO4) on a plate reader (Molecular Devices, Sunnyvale, CA) with a standard curve prepared from nitrite-containing homogenization buffer. Data were analyzed by measuring the concentration of nitrite (based on the standard curve) in the uninhibited and L-NIL–inhibited samples. Two factors were taken into consideration in the data analysis: the intrinsic coloration of the homogenate imparted by hemoglobin and significantly different protein concentrations related to differences in the size of tissues that were homogenized. To account for these factors, we divided the measured nitrite concentration in the uninhibited sample by the measured nitrite concentration in the L-NIL–inhibited control to determine the percentage of control, and then this value was divided by the mass of protein per assay. Normalized data are expressed as percentage of control per microgram protein. Unless otherwise noted, reagents were purchased from Sigma-Aldrich.

Quantitative real-time PCR

RNA was obtained from eight M. tuberculosis culture–positive (involved) and four culture-negative (uninvolved) tissues from m907, m1307, m1707, m9803, m16705, m13207, m10403, and m16705 stored in RNAlater (Life Technologies, Grand Island, NY) at −80°C at necropsy. Tissues were disrupted in TRIzol (Life Technologies) under BSL3 conditions, and RNA was isolated using a standard phenol-chloroform isolation followed by cleanup with RNeasy columns (Qiagen, Valencia, CA). RNA was quantified on a DU-800 spectrophotometer (Beckman Coulter, Brea, CA) and used for quantitative RT-PCR (qRT-PCR). Arg1 (HP200032) and Arg2 (HP205107) primers were purchased from Origene (Rockville, MD), whereas eNOS primers were purchased from Realtimeprimers.com (Elkins Park, PA). iNOS (forward: 5′-TCTTGGTCAAAGCTGTGCTC-3′; reverse: 5′-CATTGCCAAACGTACTGGTC-3′) and nNOS (forward: 5′-TAGCTTCCAGAGTGACAAAGTGACC-3′; reverse: 5′-TGTTCCAGGGATCAGGCTGGTATTC-3′) primers were based on the respective human RNA sequences and the identity of the product confirmed by sequencing. Hypoxanthine phosphoribosyltransferase mRNA (forward: 5′-TTACCTCACTGCTTTCCGGAG-3′; reverse: 5′-AGTCTGGCTTATATCCAACAT-3′) was quantified as an internal control. Unless otherwise indicated, primers were purchased from Sigma-Aldrich. Amplification was performed on an iCycler (Bio-Rad, Hercules, CA) using AMV reverse transcriptase (Promega, Madison, WI) and GoTaq qPCR Master Mix reagents (Promega). Samples were assayed in duplicate for each tissue. Relative quantification based on the ΔΔ threshold cycle method (30) with hypoxanthine phosphoribosyltransferase (also performed in duplicate) was used as a housekeeping control.

Flow cytometry to identify calprotectin as a neutrophil marker

Whole blood from macaques was isolated as previously described (31). Preliminary experiments demonstrated that Percoll gradient isolation of PBMCs from whole blood separates cells into two fractions, a lymphocyte and monocyte-rich fraction and a neutrophil and RBC-rich fraction. Neutrophils in the RBC fraction had physical characteristics that did not differ from neutrophils in RBC-lysed whole blood. Neutrophils from the RBC pellet were stained after lysing the RBCs with PharmLyse (BD Biosciences) and the cells fixed and permeablized with the Cytofix/Cytoperm and Perm/Wash buffers (BD Biosciences) for intracellular Ag staining. Cells were stained for CD163 (clone eBioGHI/61; eBioscience, San Diego, CA) and calprotectin (clone MAC387; Lab Vision) that had been labeled with the Zenon labeling kit (Life Technologies). Cells phenotypes were read using an LSRII flow cytometer (BD Biosciences).

Data analysis and statistics

Data were analyzed with GraphPad Prism 5.0 (GraphPad, La Jolla, CA). Comparisons between treatments were made using the nonparametric Mann–Whitney U test, and pairwise comparisons between granuloma regions were made using the nonparametric Wilcoxon matched-pairs signed-rank test with p < 0.05 considered statistically significant. Flow cytometric data were analyzed using the FlowJo software package (Tree Star, Ashland, OR).

Results

Arg1, Arg2, iNOS, and eNOS are expressed and functional in the granuloma

Factors initiating macrophage polarization and phenotypes of classically or alternatively activated macrophages have not been fully resolved in primates. In mice, NOS expression defines classically activated macrophages, whereas arginase expression delineates alternatively activated macrophage populations; consequently, we used Arg1, Arg2, iNOS, or eNOS (Fig. 1) as markers for macrophage function with the caveat that these markers may not fully describe macrophage polarization. Moreover, because of the difficulty assigning an activation state to primate macrophages, we will use the term proinflammatory to indicate macrophages with dominant NOS expression and anti-inflammatory to characterize macrophages with dominant arginase expression. Arg1 was abundant in macrophages, whereas the most intense Arg2 signal occurred as discrete granules in cells with segmented nuclei and at much lower levels in macrophages (Fig. 1A). iNOS and eNOS were identified in macrophages, each with a characteristic staining pattern. Macrophage iNOS had a punctate appearance and appeared to be scattered throughout the cytoplasm (Fig. 1A), whereas eNOS staining in epithelioid macrophages was more intense and associated with the cell membrane (Fig. 1A). We also found substantial iNOS and Arg1 coexpression, particularly in macrophages (Fig. 1B) but also in neutrophils (Fig. 1B). These results demonstrate that macrophage activation is not binary but occurs along a spectrum.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Immunohistochemical identification of arginase and NOS isoforms in cells from cynomolgus macaque granulomas. (A) Epithelioid macrophages, as depicted by H&E staining (H&E) were stained for Arg1, Arg2, iNOS, and eNOS (green) and nuclei (blue) and imaged at ×600 original magnification to represent the unique staining patterns associated with each enzyme. Each panel presents an independent set of epithelioid macrophages in the macrophage region. Scale bar, 20 μm. (B) Coexpression of Arg1 (red) and iNOS (green) in CD163+ macrophages (blue, top panel) and in cells with segmented neutrophil-like nuclei (arrowheads, bottom panel). Image acquired at ×600 original magnification.

qRT-PCR and biochemical assays for arginase and NOS activity confirmed that arginase and NOS are expressed and functional in granulomas. qRT-PCR indicated Arg1, Arg2, eNOS, and iNOS expression was upregulated in granuloma-containing tissues relative to uninfected control tissues (Fig. 2A), with Arg1 and iNOS upregulated more than Arg2 and eNOS, respectively. Although nNOS expression was identified, its expression in granulomas was not strongly upregulated above uninfected lung. Biochemical assays for enzyme activity in tissue lysates demonstrated that granuloma-containing tissues had significantly more arginase and NOS activity than uninvolved tissues (Fig. 2B–D). The NOS activity associated with individual granulomas within a monkey was highly variable but generally higher than the NOS activity from uninvolved lung from that same monkey (Fig. 2C). When these data were aggregated and compared, granulomas showed significantly more NOS activity than uninvolved tissue from infected animals (Fig. 2D). Although the iNOS activity of many granulomas was inhibited by L-NIL, it was not possible to inhibit the NOS activity in some tissues, suggesting other NOS isoforms contribute to NO production (data not shown). Finally, we identified nitrotyrosine, the nitrosylated tyrosine residues produced after NO–protein interactions, in granuloma macrophages and neutrophils (Fig. 2E), supporting that the NOS species present in granulomas are functional.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Granulomas contain higher levels of arginase and NOS activity and gene expression than uninvolved lung tissue. Arginase and NOS enzyme activity is from independent experiments using tissues from different animals. (A) Relative transcript quantification in which granuloma-containing tissues (n = 8) are compared against relative transcript abundance in uninvolved tissues (n = 4) from four animals. Data represent the mean ± SEM. (B) Arginase activity was measured from four uninvolved tissues and six granulomas from five monkeys. Statistical comparison by the Mann–Whitney U test. (C) NOS activity was measured from 7 uninvolved tissues (−) and 35 granulomas (+) from 6 animals (A, m23210; B, m21410; C, m22210; D, m5210; E, m22510; F, m22910) showing a trend in which involved tissues have more functional enzyme than uninvolved tissue. (D) Aggregated data from (C) indicating granulomas have significantly higher mean NOS activity than uninvolved tissues. Statistical comparison by the Mann–Whitney U test. (E) Immunohistochemical staining of a necrotic granuloma showing strong nitrotyrosine staining at the epithelioid macrophage–caseum interface (indicated by a dashed line) with significant numbers of macrophages and some cells having segmented neutrophil-like nuclei (arrows) that stain positively for nitrotyrosine (red). Scale bar, 10 μm.

Identification of macrophage- and neutrophil-specific Abs for cynomolgus macaques

Despite the abundance of macrophages in granulomas, little is known about their molecular identities. Two categories of macrophages found in human granulomas are described morphologically (33) as epithelioid macrophages and foamy macrophages. Epithelioid macrophages are defined by their high cytoplasm/nucleus ratios and diffusely eosinophilic cytoplasm (34, 35) and are particularly abundant in granuloma regions adjacent to caseous necrosis. Foamy macrophages are also associated with tuberculous granulomas and are identifiable by their foamy, lipid-rich cytoplasm (2). To better characterize the presence and location of these cells in granulomas, we used Abs against human macrophage Ags that we validated for use in macaque tissues. These Ags, including CD11c, CD68, CD163, HAM56, and calprotectin (Mac387), reliably stained cells in macaque tissues, whereas we excluded other commonly used macrophage markers, including CD11b and CD14 because of their broad myeloid cell expression. Dendritic cell–specific ICAM-3–grabbing nonintegrin (CD209), a marker associated with dendritic cells, was expressed by macrophages in throughout granulomas (data not shown) and, consequently, was not included in this study. We also excluded F4/80, a commonly used macrophage marker in murine systems because the human homolog (EMR1) is an eosinophil-associated protein (36) and CD15, a marker for human neutrophils because it expression on a subset of lymphocytes and lung epithelial cells (data not shown). These Abs can react with other structures (e.g., HAM56 and CD163 with endothelium and CD68 with fibroblasts), but endothelium is not abundant in granulomas and fibroblasts associated with granulomas did not stain positively for CD68; data not shown). Staining patterns for CD11c+, CD68+, CD163+, and HAM56+ cells were morphologically consistent with macrophage-like cells (Supplemental Fig. 1). The Ab Mac387 is often described as a macrophage marker, yet in cynomolgus macaques, the morphology of calprotectin-expressing cells was more neutrophil-like. Subsequent experiments identified calprotectin-bright cells in cynomolgus macaques as neutrophils (Supplemental Fig. 2).

Myeloid cell populations in macaque and human granulomas

In this study, we imaged granulomas representing the types commonly seen in cynomolgus macaques (5) with active TB to determine whether different, antigenically defined populations of macrophages exist in different microenvironments and how the position of these cells correlate with bacterial localization. In addition to markers of different macrophage populations, we examined the NOS and arginase expression by region to determine how microenvironments correlate with macrophage function. Macrophage activation states in primates are complex and poorly understood, so although these markers may reflect a functional capacity, we realize they cannot fully describe the full spectrum of macrophage polarization. We also imaged fibrocalcific granulomas associated with clinically latent TB to compare the organization and population structure of macrophage subsets in healed lesions with active lesions from animals that poorly controlled TB. To compare the nonhuman primate data with human data, we obtained deidentified samples from patients undergoing lung resection for recalcitrant TB; these patients are likely to have had long courses of infection and may have undergone several rounds of treatment. Under these circumstances, the pathology can be more complex than in macaques and can include extensive fibrosis. In fact, lung tissue samples obtained contained multiple granulomas that were often highly fibrotic; we selected nonnecrotic and necrotic granulomas with the lowest amount of fibrosis for imaging and were mindful that these lesions represent those from chronic, poorly controlled disease hosts.

Nonnecrotic granulomas

Nonnecrotic granulomas were characterized by dense macrophage populations without necrotic areas (Fig. 3A). CD68+ and CD163+ macrophages were most abundant at the periphery, although macrophages with lower expression of these markers could be found throughout these granulomas (Fig. 3B, 3D). Neutrophils were randomly distributed throughout nonnecrotic granulomas (Fig. 3B). HAM56+ foamy macrophages were present but were especially abundant in central regions of granulomas with higher levels of organization (Fig. 3B). The position of iNOS+ cells was similar to that observed for HAM56 expression; less organized, nonnecrotic granulomas had randomly distributed iNOS expression (Fig. 3C), whereas increasingly organized granulomas had foci of iNOS expression that was consistent with the position of epithelioid macrophages (data not shown). Similarly, eNOS expression most strongly correlated with the presence and location of epithelioid macrophages (Fig. 3D). Arg1-expressing cells were identified but did not localize to any particular region in these granulomas. Relatively few Arg2-expressing cells were identified, and most of these appeared to be in macrophages at the granuloma’s outer edge and in neutrophils dispersed throughout the granuloma (Fig. 3E).

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Macrophage phenotypes and distribution in nonnecrotic granulomas from macaques with active TB. Individual panels show serial 5-μm–thick sections of a representative nonnecrotic granuloma. (A) H&E staining (top panel) with a pseudocolored representation (bottom panel) indicating lymphocyte-rich (cyan) and epithelioid macrophage-rich (purple) regions. Black box indicates the region depicted at higher magnification in (C)–(E). (B) Macrophage-specific stains including HAM56 (red), CD163 (green), and calprotectin-stained neutrophils (blue). White box indicates the region depicted at higher magnification in (C)–(E). (C) iNOS (green) and Arg1 (red) expression with nuclei (blue). (D) CD68 (red) and eNOS (green) expression with nuclei (blue). (E) Arg2 (green) expression with nuclei (blue). Scale bars, 100 μm.

Caseous necrotic and suppurative granulomas

Necrotic and suppurative granulomas (Fig. 4) have similar features (e.g., well-defined lymphocyte cuffs and epithelioid macrophage-rich regions), but caseous granulomas have noncellular necrotic centers and suppurative granulomas have centers nearly completely infiltrated by neutrophils. Although we consider necrotic and suppurative granulomas to be defined morphotypes, they are grouped together in this study because of their similarities.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Macrophage phenotypes and distribution in necrotic and suppurative granulomas from macaques with active TB. Individual panels show serial 5-μm–thick sections of representative necrotic and suppurative granulomas. H&E staining (top panel) of necrotic (A) and suppurative (F) granulomas with pseudocolored representation (bottom panel), indicating lymphocyte-rich (cyan), epithelioid macrophage-rich (purple), and necrotic [yellow, (A)] or [suppurative yellow, (F)] regions. Black boxes indicate the regions depicted at higher magnification in (C)–(E) and (G)–(J). (B and G) Macrophage-specific stains including HAM56 (red), CD163 (green), and calprotectin-stained neutrophils (blue). White box indicates the region depicted at higher magnification in (C)–(E). (C and H) iNOS (green) and Arg1 (red) expression with nuclei (blue). (D and I) CD68 (red) and eNOS (green) expression with nuclei (blue). (E and J) Arg2 (green) expression with nuclei (blue). Scale bars, 100 μm.

CD163+ macrophages were most abundant in peripheral regions of granulomas adjacent to, or inside, the lymphocyte cuff (Figs. 4B, 4G, 5A, 5D). Clusters of strongly CD11c+CD68+CD163+ alveolar macrophage-like cells were often immediately adjacent to the lymphocyte cuff (Fig. 5A, arrowheads). Epithelioid macrophages were CD163− or CD163dim but often strongly expressed CD68 (Fig. 4D, 4I, 5A, 5C) and CD11c (Fig. 5B). HAM56+ foamy macrophages were most abundant on the rim of the caseous or neutrophilic center (Fig. 4B, 4G) with more elongate cellular morphology extending perpendicular to the center of the granuloma. Calprotectin+ neutrophils were present in the lymphocyte cuff and macrophage-rich regions but were most abundant in areas near the HAM56+ foamy macrophages adjacent to the caseum (Fig. 4B) and centers of suppurative granulomas (Fig. 4G). Arg1 expression was observed throughout the cellular regions of granulomas (Fig. 4C, 4H), but was most strongly expressed by cells in the lymphocyte cuff (Fig. 5F). Epithelioid macrophages and lymphocyte cuff macrophages also expressed iNOS (Figs. 4C, 4H, 5E), with more iNOS signal observed in lymphocyte cuff region. The lymphocyte cuff region is significantly more cellular than the epithelioid macrophage region (mean density, 6373 nuclei/mm2 versus 4459 nuclei/mm2, respectively; p = 0.0008, Mann–Whitney U test; n = 9 granulomas) and contains a residual population of epithelial cells that are iNOS rich; consequently, this figure may overrepresent macrophage iNOS expression in the lymphocyte cuff region. When the ratio of iNOS/Arg1 signal intensity from epithelioid macrophages and lymphocyte cuff regions was calculated, epithelioid macrophages expressed significantly more iNOS relative to Arg1 than cells in the lymphocyte cuff region (Fig. 5G), suggesting that Arg1 expression differentiates NO-generating capacity of macrophages in the epithelioid macrophage and lymphocyte cuff regions.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Region-specific expression of macrophage markers iNOS and Arg1 in necrotic granulomas. (A) A necrotic granuloma stained for CD11c (red), CD68 (green), and CD163 (blue) showing distinct stratification of cell populations. Arrowheads indicate clusters of CD11c+CD68+CD163+ alveolar macrophage-like cells. Original magnification ×100. Scale bar, 100 μm. (B–G) Image analysis of necrotic granulomas comparing fluorescence signal intensity of epithelioid macrophage and lymphocyte cuff regions in necrotic granulomas from four monkeys [(B)–(D), n = 37 fields from 18 granulomas; (E)–(G), n = 30 fields from 18 granulomas]. The fields imaged for (B)–(D) are different from panels (E)–(G) but come from granulomas in the same tissue section. (B) CD11c. (C) CD68. (D) CD163. (E) iNOS. (F) Arg1. (G) Ratio of iNOS/Arg1 signal intensity showing decreased Arg1 expression in epithelioid macrophage region relative to the lymphocyte cuff. Pairwise comparisons by the Wilcoxon matched-pairs signed-rank test. *p = 0.062, **p < 0.0001.

Strong eNOS expression was also noted in epithelioid macrophages, with the majority of eNOS associated with the plasma membrane (Fig. 4D, 4I). We also observed smaller cells in the lymphocyte cuff that were strongly positive for cytoplasmic eNOS but did not stain for either macrophage or endothelial markers (CD31, von Willebrand factor; data not shown). Arg2 expression was largely associated with neutrophils at the border of the caseum and in the center of suppurative granulomas (Fig. 4E, 4J).

Fibrocalcific granulomas

Small numbers of fibrocalcific granulomas are commonly found in latently infected hosts, but also in active TB, and are likely to represent the successful outcome of an effective immune response. These granulomas commonly contain mineralized material surrounded by fibrotic tissue and limited numbers of lymphocytes and macrophages (Fig. 6A). Many of the cells in the fibrotic region surrounding mineralized centers expressed CD163 (Fig. 6B). These granulomas contained very few neutrophils (Fig. 6B), HAM56+ (Fig. 6B) and CD68+ (Fig. 6D) macrophages, or eNOS-expressing macrophages (Fig. 6D). iNOS and Arg1 were expressed in the cells closest to the mineralized material (Fig. 6C). Arg2 expression was minimal, but strong signal was noted at the fibrosis–mineral interface (Fig. 6E).

FIGURE 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 6.

Macrophage phenotypes and distribution in fibrocalcific granulomas from macaques with latent TB. Individual panels show serial 5-μm–thick sections of a representative necrotic granuloma. (A) H&E (top panel) with pseudocolored representation (bottom panel) indicating the outer fibrotic region (cyan), fibrocalcific interface (purple), and central region containing mineralized material (yellow) that shattered during cutting. Dashed line indicates portion of the fibrocalcific interface that is separated from the rest of the granuloma and is present as an artifact in (A). Black box indicates the region depicted at higher magnification in (C)–(E). (B) Macrophage-specific stains including HAM56 (red), CD163 (green), and calprotectin-stained neutrophils (blue). Gray line outlines the tissue edge denoted by the dashed line in (A) where the fibrocalcific interface has separated from the surrounding tissue and reflected over the other side. White box indicates the region depicted at higher magnification in (C)–(E). (C) iNOS (green) and Arg1 (red) expression with nuclei (blue). (D) CD68 (red) and eNOS (green) expression with nuclei (blue). (E) Arg2 (green) expression with nuclei (blue). Scale bars, 100 μm.

Bacteria are present in multiple areas in the granuloma

The localization of bacterial populations is poorly understood for primate granulomas. We stained granulomas for the presence of mycobacterial cell wall components with auramine-rhodamine with overlaid H&E-stained features to correlate the positions of bacteria and different macrophage populations. Ongoing studies in our laboratory where homogenized granulomas are plated for bacterial culture indicate that numbers of bacteria per granuloma are variable and generally low, ranging from sterile granulomas to 106 bacteria/granuloma (J.L.F. and P.L.L., manuscript in preparation). M. tuberculosis were often not abundant in granulomas, with most granulomas having either no or very small numbers of visible bacteria per 5-μm tissue section. In granulomas in which bacteria were visible, bacilli were present in a variety of locations, including in epithelioid macrophages (Fig. 7A), intermixed with neutrophils at the caseum–macrophage interface (Fig. 7A), and in giant cells at the granuloma’s periphery (Fig. 7B). Bacteria were most commonly present as small groups of individual bacilli associated with necrotic appearing cells at the caseum–macrophage interface. Small numbers of individual bacilli were also occasionally visible deep in the necrotic regions of caseous lesions (Fig. 7B). Auramine-rhodamine–stained objects that did not appear to be intact bacteria were also occasionally visible in epithelioid macrophages adjacent to foamy macrophages with elongated morphologies consistent with foamy HAM56+ cells (Fig. 7C). Interestingly, fibrotic granulomas from latent disease contained a ring of auramine-rhodamine–stained mycolic acid at the fibroblast-collagen–transformed caseum interface (Fig. 7D), suggesting persistence and diffusion of bacterial Ag after most of the bacteria appeared to have been cleared.

FIGURE 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 7.

Bacteria and bacterial Ags can be detected in granulomas from active and latent disease. Auramine-rhodamine images (red images overlaid on grayscale H&E backgrounds) indicating the presence of mycobacteria in granulomas come from regions indicated by white boxes in the colored H&E-stained granuloma. Auramine-rhodamine stains come from the same tissue section as the H&E-stained image. (A) A necrotic granuloma with large numbers of neutrophils infiltrating into the caseum showing bacteria in epithelioid macrophages (top panel) and admixed with macrophage and neutrophils (bottom panel). (B) A necrotic granuloma with bacilli in giant cells in the granuloma periphery (top panel) and in the caseum (bottom panel). (C) A necrotic granuloma showing mycobacterial Ags and bacilli in epithelioid macrophages (top panel) and adjacent to foamy macrophages and mycobacterial Ags in the caseum (bottom panel). (D) A fibrotic granuloma from an animal with latent TB showing residual mycobacterial Ags at the interface of highly fibrotic tissue (top and bottom panels). Scale bars, 200 μm.

Nonnecrotic and necrotic granulomas from humans are similar to cynomolgus macaques with respect to macrophage subset, NOS, and arginase localization

The organization of macrophage subsets in nonnecrotic and necrotic human granulomas was grossly similar to macaque granulomas. In nonnecrotic human granulomas (Fig. 8A), CD163+ macrophages were present throughout the granuloma, with cells in the outer regions commonly coexpressing HAM56 (Fig. 7B). Necrotic granulomas (Fig. 8F) had large numbers of CD163+HAM56+ macrophages in the peripheral tissue, whereas cells in the lymphocyte cuff were more likely to be CD163+HAM56− (Fig. 8G). Although HAM56 staining adjacent to the caseum was observed, it was not as intense or as distinct as it was in macaque granulomas. Epithelioid macrophages in nonnecrotic and necrotic granulomas strongly expressed CD68 (Fig. 8D, 8I). Clusters of macrophages in the peripheral tissue surrounding these granulomas were HAM56+CD68+CD163+ (arrows, Fig. 8G, 8I), whereas these clusters in macaques were HAM56−CD68+CD163+ (data not shown). Calprotectin-expressing neutrophils were present, and their distribution in nonnecrotic granulomas was similar to that observed in macaque granulomas (Fig. 8B). Although we observed neutrophils in necrotic granulomas, they were not as numerous as they were in macaque granulomas and did not appear to accumulate at the macrophage–caseum interface (Fig. 8G).

FIGURE 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 8.

Macrophage phenotypes and distribution in nonnecrotic and necrotic human granulomas. (A–E) indicate images of a nonnecrotic granuloma. (F–J) indicate images of a necrotic granuloma. Black boxes (H&E images) and white boxes (HAM56, CD163, calprotectin images) denote areas shown in the higher magnification Arg1/iNOS, CD68/eNOS, and Arg2 panels. (A and F) H&E staining. (B and G) Macrophage-specific stains including HAM56 (red), CD163 (green), and calprotectin-stained neutrophils (blue). (C and H) iNOS (green) and Arg1 (red) expression with nuclei (blue). (D and I) CD68 (red) and eNOS (green) expression with nuclei (blue). Arrows indicate clusters of CD68+eNOS+ cells adjacent to the granuloma. (E and J) Arg2 (green) expression with nuclei (blue). Scale bars, 50 μm.

iNOS was expressed at low levels by macrophages distributed throughout human nonnecrotic granulomas or adjacent to caseum in necrotic granulomas (Fig. 8C, 8H). Unidentified cells expressing high levels of iNOS were present in regions of nonnecrotic granulomas and in the lymphocyte cuff of necrotic granulomas. Similarly stained cells were observed in some macaque granulomas. CD68+ macrophages in human granulomas frequently expressed eNOS (Fig. 8D, 8I), and clusters of HAM56+CD68+CD163+ macrophages in the tissue adjacent to granulomas stained particularly strong for eNOS (arrows). Arg1 expression was similar that seen in macaque granulomas: Arg1 staining was visible throughout cellular regions of granulomas with little evidence for region-specific expression and Arg1 expression frequently occurred in cells that also expressed iNOS (Fig. 8C, 8H). As has been previously reported (25), there was little Arg2 expressed in human granulomas. Human granulomas contained scattered Arg2-expressing cells, but Arg2 staining did not appear to be as tightly correlated with neutrophils as it was in macaque granulomas (Fig. 8E, 8J).

Discussion

Large populations of macrophages are a prominent feature of tuberculous granulomas, yet there are many unanswered questions surrounding the spatial organization of macrophage subsets in granulomas and whether macrophages have microenvironment-specific homeostatic or bactericidal functions. Much of what we know about granuloma macrophages comes from animal models that may not represent the spectrum of pathology seen in humans or has been derived from cells removed from the context of the granuloma. To address these questions, we used immunohistochemistry to clarify the interplay of microenvironment and macrophage biology by identifying macrophage subsets and arginase and NOS expression in granulomas from cynomolgus macaques, a nonhuman primate that recapitulates human TB (4). We found that granulomas have macrophage subsets that are stratified into pro- and anti-inflammatory regions with the implication that this organization may limit immunopathogenic antimicrobial activity to bacteria-rich microenvironments by surrounding them with a layer of cells with anti-inflammatory phenotypes.

The importance of NOS in human TB is controversial (36–38). In mice, elimination of NO leads to higher bacterial numbers and decreased survival time (9, 38). M. tuberculosis has limited sensitivity to NO-mediated killing (39–41), and mice with functional iNOS still die of TB, demonstrating that nitrogen radical production alone does not correlate with protection. Humans with TB also express iNOS (12–14), but even though they do not generate NO as vigorously as mice, the human immune system is better at containing M. tuberculosis, and most infections do not progress to active TB. Our data demonstrate that macaque macrophages can express NOS, and granulomas have higher eNOS and iNOS expression than uninfected lung tissue. Epithelioid macrophages can be associated with M. tuberculosis bacilli in granulomas and iNOS and eNOS expression, with low levels of Arg1 expression, suggests that NO production by these cells is an active component of the anti–M. tuberculosis response in macaques. Fibrocalcific granulomas associated with latent M. tuberculosis infection also had iNOS-positive cells, implying that even successful immune responses during latency retain low levels of iNOS expression. This population of iNOS-expressing cells remains in place, presumably either because stimulus is provided by residual mycobacterial Ags or the low numbers of viable bacilli that may be present in these lesions. The surprising amount of eNOS in granulomas in active disease brings up the question of whether it participates in protection against M. tuberculosis. Its localization to plasma membranes instead of phagosome-like structures suggests it may not be appropriately positioned to target intracellular bacteria. Alternatively, eNOS produces superoxide when uncoupled if tetrahydrobiopterin or l-arginine are limiting (42, 43) or through protein kinase Cζ–mediated processes following exposure to hypochlorous acid (44). Superoxide in the presence of NO generates peroxynitrite, which is lethal to M. tuberculosis (45). There remains much to be learned about epithelioid macrophage biology in situ, and eNOS expression may serve alternative functions that are not directly bactericidal but still contribute to protection. However, NO may also downregulate immune responses in the granuloma; for example, by inhibiting T cell functions as has been demonstrated in other experimental systems (20, 46–48) or by limiting inflammasome activation and subsequent IL-1β secretion (49).

Arginases can compete with NOS for l-arginine, thereby downregulating NO production and generating l-ornithine, an amino acid that can be used for proline synthesis (18), which is used for synthesis of proline-rich proteins such as collagen in granulomas, wound healing, and fibrotic tissues or for polyamine synthesis (18). In mice, Arg1 expression occurs in M2-polarized (anti-inflammatory) macrophages (16, 50, 51) and in wound healing macrophages (52). It has been demonstrated that conversion of arginine to proline in anti-inflammatory macrophages is dependent on Arg1 (53), consistent with the notion that arginase-derived ornithine may promote synthesis of collagen (leading to fibrosis) in tuberculous granulomas. However, ablation of macrophage Arg1 expression resulted in increased fibrosis in mice infected with Schistosoma mansoni (20), indicating that fibrosis may not be enhanced by Arg1 in all circumstances. Arginase expression is correlated with decreased protection against acute M. tuberculosis infection in mice (23, 24), likely reflecting depletion of l-arginine substrate for NO synthesis. Protective immune responses against M. tuberculosis may require both proinflammatory macrophages with bactericidal activity and prohealing anti-inflammatory macrophages to limit immunopathology. Moreover, primate granulomas are highly organized, and protection would be contingent upon appropriate spatial expression of NOS and arginase expression. Because of this, we hypothesized Arg1−NOS+ macrophages would be present in bacilli-rich microenvironments and Arg1+NOS− macrophages along the outer margins. Instead, we found substantial coexpression of NOS and arginase throughout necrotic granulomas and elevated Arg1 expression in the lymphocyte cuff region, indicating the ratio of NOS/arginase expression is most likely to be a factor determining functional macrophage polarity in primates. The paucity of Arg1 expression in epithelioid macrophages also suggests that competition for l-arginine by Arg1 may be a critical posttranscriptional determinant of macrophage polarity and NOS activity in primate tuberculous granulomas. The abundance of l-arginine–using enzymes in granulomas may also lead to l-arginine depletion. Consequences of this depletion on T cell function may include downregulation of T cell TCR-ζ expression (46, 47), activation (47, 48), proliferation (47, 48) and cytokine secretion (20, 47). Thus, arginase and NOS expression may decrease proinflammatory T cell responses and modulate macrophage function.

Macrophage diversity and spatial organization of cells within granulomas are significant yet underappreciated aspects of the biology of TB. Alveolar macrophages in cynomolgus macaques are predominately CD11c+CD68+CD163+, but macrophage phenotypes in the granuloma are considerably more complex. CD163 expression delineated two macrophage subsets: CD11c+CD68+CD163+/CD68−CD163+ cells and CD68+CD163dim/CD68+CD163− cells. CD163 expression has been identified as a marker of alternative activation (M2) (51, 54), and the abundance of these cells in outer regions of granulomas are phospho-STAT3 positive (data not shown), an indicator of IL-10 signaling in alternatively activated macrophages (55, 56), and have a lower ratio of iNOS/Arg1 expression relative to epithelioid macrophages suggests these cells may not be actively bactericidal. In contrast, CD11c+CD68+CD163− epithelioid macrophages are present in regions with the largest number of bacteria or bacterial Ags and had classically activated NOS-expressing phenotypes. HAM56, a reported marker for foamy macrophages (57–59), was also associated with cells at the epithelioid macrophage–caseum interface, a position similar to the location of Oil Red O–stained macrophages in human granulomas (2, 60). In addition to acting as mediators of l-arginine metabolism in granulomas, granuloma macrophages may be important sources of proinflammatory and anti-inflammatory cytokine production that may also influence how successful a granuloma is at containing bacterial replication and dissemination.

The epithelioid macrophage–caseum interface also contained significant numbers of neutrophils. The role of neutrophils in TB is controversial (61). Murine TB models indicate neutrophil infiltration is enabled by impaired adaptive immune responses and leads to increased pathology and accelerated disease progression (62), and a neutrophil transcriptional signature in human blood differentiated persons with active TB or latent infection (63). Similarly, granulomas from cynomolgus macaques with poorly controlled TB can contain large numbers of neutrophils (5), oftentimes in close proximity to bacilli. M. tuberculosis is resistant to neutrophil-mediated killing (61, 64), and neutrophils in the airways of TB patients commonly contain replicating M. tuberculosis (65). Moreover, neutrophil cytosol is rich in calprotectin, an antimicrobial peptide that is supportive of M. tuberculosis growth in vitro (66), further suggesting they are not restricting survival and replication. Moreover, the proximity of degenerating neutrophils with bacilli suggests it is also possible that these cells may provide a nutrient source for M. tuberculosis. Neutrophils in granulomas can express iNOS and stain positively for nitrotyrosine, demonstrating that they generate NO but it is unknown whether this influences bacterial containment. In addition to commonly considered neutrophil effector mechanisms, neutrophils can express cytokines including TNF, IL-1β, IL-12, and vascular endothelial growth factor (67, 68) and participate in cross-priming of CD8+ T cells (69), suggesting neutrophils may exert unappreciated and unknown effects on protection.

These data on macrophage phenotypes, neutrophil distribution, and immune function present a dynamic granuloma-scale picture of immune function in human and primate granulomas. Active lesions display a gradient of anti- and proinflammatory phenotypes, with anti-inflammatory CD163+iNOS+Arg1high macrophages on outer margins and proinflammatory CD11C+CD68+CD163dimiNOS+eNOS+Arg1low macrophages toward the center, thus making it possible to mount antibacterial responses safely away from uninvolved tissue. Fibrocalcific granulomas retain aspects of this gradient, but the macrophage populations are biased toward anti-inflammatory phenotypes (CD68−CD163+), possibly due to lower numbers of bacilli in these granulomas (70). iNOS expression still occurs in these granulomas, suggesting some continued presence of antimycobacterial activity is required for controlling any bacteria remaining in these lesions. The concept of a cell and effector gradient is also supported by mathematical modeling (28). A better understanding of what constitutes a protective macrophage phenotype in a particular microenvironment and techniques to promote specific macrophage phenotypes may provide important avenues for immunotherapeutic treatment of TB.

Disclosures

The authors have no financial conflicts of interest.

Acknowledgments

We thank Jennifer Linderman and Nicholas Clifone for critical reading of the manuscript and helpful discussions. We also thank the patients and staff of National Masan Tuberculosis Hospital for time and participation in our studies and the Flynn laboratory for helpful discussions and excellent veterinary staff.

Footnotes

  • This work was supported by National Institutes of Health (NIH) Grants HL074845 (to J.L.F.), HL106804 (to J.L.F. and D.E.K.), HL092883 (to J.L.F. and D.E.K.), EB012579 (to D.E.K. and J.L.F.), GM057384-11 (to S.M.M.); the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH and the Korean Ministry of Health, Welfare and Family Affairs (to C.E.B.); NIH Grant AI060525-05 (to J.L.F., supporting J.T.M.); NIH Grant AI077183 (to J.T.M.); the Bill and Melinda Gates Foundation (to J.L.F., P.L.L., and C.E.B.); NIH Grant K08 AI063101 (to P.L.L.); the Otis Foundation (to P.L.L.); and the Heiser Program for Research in Tuberculosis and Leprosy (to J.T.M.).

  • The online version of this article contains supplemental material.

  • Abbreviations used in this article:

    Arg
    arginase
    eNOS
    endothelial NO synthase
    iNOS
    inducible NO synthase
    L-NIL
    N6-​(1-​iminoethyl)-​l-​lysine
    nNOS
    neural NO synthase
    NOS
    NO synthase
    qRT-PCR
    quantitative RT-PCR
    TB
    tuberculosis.

  • Received January 14, 2013.
  • Accepted May 7, 2013.

References

  1. ↵
    1. Lawn S. D.,
    2. A. I. Zumla
    . 2011. Tuberculosis. Lancet 378: 57–72.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Russell D. G.,
    2. P. J. Cardona,
    3. M. J. Kim,
    4. S. Allain,
    5. F. Altare
    . 2009. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat. Immunol. 10: 943–948.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Flynn J. L.,
    2. E. Klein
    , eds. 2010. Pulmonary Tuberculosis in Monkeys. CRC Press, Taylor & Francis Publishers, Boca Raton, FL.
  4. ↵
    1. Capuano S. V., III.,
    2. D. A. Croix,
    3. S. Pawar,
    4. A. Zinovik,
    5. A. Myers,
    6. P. L. Lin,
    7. S. Bissel,
    8. C. Fuhrman,
    9. E. Klein,
    10. J. L. Flynn
    . 2003. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect. Immun. 71: 5831–5844.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Lin P. L.,
    2. M. Rodgers,
    3. L. Smith,
    4. M. Bigbee,
    5. A. Myers,
    6. C. Bigbee,
    7. I. Chiosea,
    8. S. V. Capuano,
    9. C. Fuhrman,
    10. E. Klein,
    11. J. L. Flynn
    . 2009. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect. Immun. 77: 4631–4642.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Leong F.,
    2. E. Seokyong,
    3. V. Laura,
    4. B. Clifton
    . 2010. Pathology of Tuberculosis in the Human Lung. In A Color Atlas of Comparative Pathology of Pulmonary Tuberculosis. Leong F. J., V. Dartois, T. Dick, eds. CRC Press, Boca Raton, FL, p. 53–81.
  7. ↵
    1. Marino S.,
    2. J. J. Linderman,
    3. D. E. Kirschner
    . 2011. A multifaceted approach to modeling the immune response in tuberculosis. Wiley Interdiscip Rev Syst Biol Med 3: 479–489.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Ray J. C.,
    2. J. L. Flynn,
    3. D. E. Kirschner
    . 2009. Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection. J. Immunol. 182: 3706–3717.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Adams L. B.,
    2. M. C. Dinauer,
    3. D. E. Morgenstern,
    4. J. L. Krahenbuhl
    . 1997. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuber. Lung Dis. 78: 237–246.
    OpenUrlCrossRefPubMed
    1. MacMicking J. D.,
    2. R. J. North,
    3. R. LaCourse,
    4. J. S. Mudgett,
    5. S. K. Shah,
    6. C. F. Nathan
    . 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94: 5243–5248.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Scanga C. A.,
    2. V. P. Mohan,
    3. K. Tanaka,
    4. D. Alland,
    5. J. L. Flynn,
    6. J. Chan
    . 2001. The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice. Infect. Immun. 69: 7711–7717.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Choi H. S.,
    2. P. R. Rai,
    3. H. W. Chu,
    4. C. Cool,
    5. E. D. Chan
    . 2002. Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 166: 178–186.
    OpenUrlCrossRefPubMed
    1. Schön T.,
    2. G. Elmberger,
    3. Y. Negesse,
    4. R. H. Pando,
    5. T. Sundqvist,
    6. S. Britton
    . 2004. Local production of nitric oxide in patients with tuberculosis. Int. J. Tuberc. Lung Dis. 8: 1134–1137.
    OpenUrlPubMed
  12. ↵
    1. Nicholson S.,
    2. Mda. G. Bonecini-Almeida,
    3. J. R. Lapa e Silva,
    4. C. Nathan,
    5. Q. W. Xie,
    6. R. Mumford,
    7. J. R. Weidner,
    8. J. Calaycay,
    9. J. Geng,
    10. N. Boechat,
    11. et al
    . 1996. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183: 2293–2302.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Nathan C.,
    2. M. U. Shiloh
    . 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 97: 8841–8848.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Gordon S.,
    2. F. O. Martinez
    . 2010. Alternative activation of macrophages: mechanism and functions. Immunity 32: 593–604.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Byers D. E.,
    2. M. J. Holtzman
    . 2011. Alternatively activated macrophages and airway disease. Chest 140: 768–774.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Morris S. M., Jr..
    2007. Arginine metabolism: boundaries of our knowledge. J. Nutr. 137(Suppl 2)1602S–1609S.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Shearer J. D.,
    2. J. R. Richards,
    3. C. D. Mills,
    4. M. D. Caldwell
    . 1997. Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am. J. Physiol. 272: E181–E190.
    OpenUrl
  18. ↵
    1. Pesce J. T.,
    2. T. R. Ramalingam,
    3. M. M. Mentink-Kane,
    4. M. S. Wilson,
    5. K. C. El Kasmi,
    6. A. M. Smith,
    7. R. W. Thompson,
    8. A. W. Cheever,
    9. P. J. Murray,
    10. T. A. Wynn
    . 2009. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 5: e1000371.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Pegg A. E.
    2009. Mammalian polyamine metabolism and function. IUBMB Life 61: 880–894.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Barron L.,
    2. T. A. Wynn
    . 2011. Macrophage activation governs schistosomiasis-induced inflammation and fibrosis. Eur. J. Immunol. 41: 2509–2514.
    OpenUrlCrossRefPubMed
  21. ↵
    1. El Kasmi K. C.,
    2. J. E. Qualls,
    3. J. T. Pesce,
    4. A. M. Smith,
    5. R. W. Thompson,
    6. M. Henao-Tamayo,
    7. R. J. Basaraba,
    8. T. König,
    9. U. Schleicher,
    10. M. S. Koo,
    11. et al
    . 2008. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9: 1399–1406.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Schreiber T.,
    2. S. Ehlers,
    3. L. Heitmann,
    4. A. Rausch,
    5. J. Mages,
    6. P. J. Murray,
    7. R. Lang,
    8. C. Hölscher
    . 2009. Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J. Immunol. 183: 1301–1312.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Pessanha A. P.,
    2. R. A. Martins,
    3. A. L. Mattos-Guaraldi,
    4. A. Vianna,
    5. L. O. Moreira
    . 2012. Arginase-1 expression in granulomas of tuberculosis patients. FEMS Immunol. Med. Microbiol. 66: 265–268.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Zea A. H.,
    2. K. S. Culotta,
    3. J. Ali,
    4. C. Mason,
    5. H. J. Park,
    6. J. Zabaleta,
    7. L. F. Garcia,
    8. A. C. Ochoa
    . 2006. Decreased expression of CD3zeta and nuclear transcription factor kappa B in patients with pulmonary tuberculosis: potential mechanisms and reversibility with treatment. J. Infect. Dis. 194: 1385–1393.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Mosser D. M.
    2003. The many faces of macrophage activation. J. Leukoc. Biol. 73: 209–212.
    OpenUrlFREE Full Text
  26. ↵
    1. Fallahi-Sichani M.,
    2. M. A. Schaller,
    3. D. E. Kirschner,
    4. S. L. Kunkel,
    5. J. J. Linderman
    . 2010. Identification of key processes that control tumor necrosis factor availability in a tuberculosis granuloma. PLOS Comput. Biol. 6: e1000778.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Kepka-Lenhart D.,
    2. D. E. Ash,
    3. S. M. Morris
    . 2008. Determination of mammalian arginase activity. Methods Enzymol. 440: 221–230.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Livak K. J.,
    2. T. D. Schmittgen
    . 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Pawar S. N.,
    2. J. T. Mattila,
    3. T. J. Sturgeon,
    4. P. L. Lin,
    5. O. Narayan,
    6. R. C. Montelaro,
    7. J. L. Flynn
    . 2008. Comparison of the effects of pathogenic simian human immunodeficiency virus strains SHIV-89.6P and SHIV-KU2 in cynomolgus macaques. AIDS Res. Hum. Retroviruses 24: 643–654.
    OpenUrlCrossRefPubMed
    1. El-Zammar O. A.,
    2. A. L. Katzenstein
    . 2007. Pathological diagnosis of granulomatous lung disease: a review. Histopathology 50: 289–310.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Jones T. C.,
    2. R. D. Hunt,
    3. N. W. King
    . 1997. Veterinary Pathology. Williams & Wilkins, Baltimore, MD.
  31. ↵
    1. Turk J. L.,
    2. R. B. Narayanan
    . 1982. The origin, morphology, and function of epithelioid cells. Immunobiology 161: 274–282.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Hamann J.,
    2. N. Koning,
    3. W. Pouwels,
    4. L. H. Ulfman,
    5. M. van Eijk,
    6. M. Stacey,
    7. H. H. Lin,
    8. S. Gordon,
    9. M. J. Kwakkenbos
    . 2007. EMR1, the human homolog of F4/80, is an eosinophil-specific receptor. Eur. J. Immunol. 37: 2797–2802.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Chan E. D.,
    2. J. Chan,
    3. N. W. Schluger
    . 2001. What is the role of nitric oxide in murine and human host defense against tuberculosis?Current knowledge. Am. J. Respir. Cell Mol. Biol. 25: 606–612.
    OpenUrlCrossRefPubMed
  34. Nathan, C. 2006. Role of iNOS in human host defense. Science 312: 1874–1875; author reply 1874–1875.
  35. ↵
    1. Nathan C.
    2002. Inducible nitric oxide synthase in the tuberculous human lung. Am. J. Respir. Crit. Care Med. 166: 130–131.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Lee W. L.,
    2. B. Gold,
    3. C. Darby,
    4. N. Brot,
    5. X. Jiang,
    6. L. P. de Carvalho,
    7. D. Wellner,
    8. G. St John,
    9. W. R. Jacobs Jr..,
    10. C. Nathan
    . 2009. Mycobacterium tuberculosis expresses methionine sulphoxide reductases A and B that protect from killing by nitrite and hypochlorite. Mol. Microbiol. 71: 583–593.
    OpenUrlCrossRefPubMed
    1. Ohno H.,
    2. G. Zhu,
    3. V. P. Mohan,
    4. D. Chu,
    5. S. Kohno,
    6. W. R. Jacobs Jr..,
    7. J. Chan
    . 2003. The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis. Cell. Microbiol. 5: 637–648.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Darwin K. H.,
    2. S. Ehrt,
    3. J. C. Gutierrez-Ramos,
    4. N. Weich,
    5. C. F. Nathan
    . 2003. The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science 302: 1963–1966.
    OpenUrlAbstract/FREE Full Text
  38. ↵
    1. Werner E. R.,
    2. A. C. Gorren,
    3. R. Heller,
    4. G. Werner-Felmayer,
    5. B. Mayer
    . 2003. Tetrahydrobiopterin and nitric oxide: mechanistic and pharmacological aspects. Exp. Biol. Med. (Maywood) 228: 1291–1302.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    1. Alp N. J.,
    2. K. M. Channon
    . 2004. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler. Thromb. Vasc. Biol. 24: 413–420.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Xu J.,
    2. Z. Xie,
    3. R. Reece,
    4. D. Pimental,
    5. M. H. Zou
    . 2006. Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid: role of NAD(P)H oxidase-derived superoxide and peroxynitrite. Arterioscler. Thromb. Vasc. Biol. 26: 2688–2695.
    OpenUrlAbstract/FREE Full Text
  41. ↵
    1. Yu K.,
    2. C. Mitchell,
    3. Y. Xing,
    4. R. S. Magliozzo,
    5. B. R. Bloom,
    6. J. Chan
    . 1999. Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion. Tuber. Lung Dis. 79: 191–198.
    OpenUrlCrossRefPubMed
  42. ↵
    1. Rodriguez P. C.,
    2. A. H. Zea,
    3. J. DeSalvo,
    4. K. S. Culotta,
    5. J. Zabaleta,
    6. D. G. Quiceno,
    7. J. B. Ochoa,
    8. A. C. Ochoa
    . 2003. L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J. Immunol. 171: 1232–1239.
    OpenUrlAbstract/FREE Full Text
  43. ↵
    1. Zea A. H.,
    2. P. C. Rodriguez,
    3. K. S. Culotta,
    4. C. P. Hernandez,
    5. J. DeSalvo,
    6. J. B. Ochoa,
    7. H. J. Park,
    8. J. Zabaleta,
    9. A. C. Ochoa
    . 2004. L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. Cell. Immunol. 232: 21–31.
    OpenUrlCrossRefPubMed
  44. ↵
    1. Choi B. S.,
    2. I. C. Martinez-Falero,
    3. C. Corset,
    4. M. Munder,
    5. M. Modolell,
    6. I. Müller,
    7. P. Kropf
    . 2009. Differential impact of L-arginine deprivation on the activation and effector functions of T cells and macrophages. J. Leukoc. Biol. 85: 268–277.
    OpenUrlAbstract/FREE Full Text
  45. ↵
    1. Mishra B. B.,
    2. V. A. Rathinam,
    3. G. W. Martens,
    4. A. J. Martinot,
    5. H. Kornfeld,
    6. K. A. Fitzgerald,
    7. C. M. Sassetti
    . 2013. Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β. Nat. Immunol. 14: 52–60.
    OpenUrlCrossRefPubMed
  46. ↵
    1. Biswas S. K.,
    2. A. Mantovani
    . 2010. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11: 889–896.
    OpenUrlCrossRefPubMed
  47. ↵
    1. Cassol E.,
    2. L. Cassetta,
    3. M. Alfano,
    4. G. Poli
    . 2010. Macrophage polarization and HIV-1 infection. J. Leukoc. Biol. 87: 599–608.
    OpenUrlAbstract/FREE Full Text
  48. ↵
    1. Daley J. M.,
    2. S. K. Brancato,
    3. A. A. Thomay,
    4. J. S. Reichner,
    5. J. E. Albina
    . 2010. The phenotype of murine wound macrophages. J. Leukoc. Biol. 87: 59–67.
    OpenUrlAbstract/FREE Full Text
  49. ↵
    1. Hesse M.,
    2. M. Modolell,
    3. A. C. La Flamme,
    4. M. Schito,
    5. J. M. Fuentes,
    6. A. W. Cheever,
    7. E. J. Pearce,
    8. T. A. Wynn
    . 2001. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167: 6533–6544.
    OpenUrlAbstract/FREE Full Text
  50. ↵
    1. Niino D.,
    2. Y. Komohara,
    3. T. Murayama,
    4. R. Aoki,
    5. Y. Kimura,
    6. K. Hashikawa,
    7. J. Kiyasu,
    8. M. Takeuchi,
    9. N. Suefuji,
    10. Y. Sugita,
    11. et al
    . 2010. Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL). Pathol. Int. 60: 278–283.
    OpenUrlCrossRefPubMed
  51. ↵
    1. Stumpo R.,
    2. M. Kauer,
    3. S. Martin,
    4. H. Kolb
    . 1999. Alternative activation of macrophage by IL-10. Pathobiology 67: 245–248.
    OpenUrlCrossRefPubMed
  52. ↵
    1. Niemand C.,
    2. A. Nimmesgern,
    3. S. Haan,
    4. P. Fischer,
    5. F. Schaper,
    6. R. Rossaint,
    7. P. C. Heinrich,
    8. G. Müller-Newen
    . 2003. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J. Immunol. 170: 3263–3272.
    OpenUrlAbstract/FREE Full Text
  53. ↵
    1. Ihling C.,
    2. H. R. Göbel,
    3. A. Lippoldt,
    4. S. Wessels,
    5. M. Paul,
    6. H. E. Schaefer,
    7. A. M. Zeiher
    . 1996. Endothelin-1-like immunoreactivity in human atherosclerotic coronary tissue: a detailed analysis of the cellular distribution of endothelin-1. J. Pathol. 179: 303–308.
    OpenUrlCrossRefPubMed
    1. Cummings T. J.,
    2. C. M. Hulette,
    3. S. H. Bigner,
    4. G. J. Riggins,
    5. R. E. McLendon
    . 2001. Ham56-immunoreactive macrophages in untreated infiltrating gliomas. Arch. Pathol. Lab. Med. 125: 637–641.
    OpenUrlPubMed
  54. ↵
    1. Oleszak E. L.,
    2. E. Zaczynska,
    3. M. Bhattacharjee,
    4. C. Butunoi,
    5. A. Legido,
    6. C. D. Katsetos
    . 1998. Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis. Clin. Diagn. Lab. Immunol. 5: 438–445.
    OpenUrlPubMed
  55. ↵
    1. Peyron P.,
    2. J. Vaubourgeix,
    3. Y. Poquet,
    4. F. Levillain,
    5. C. Botanch,
    6. F. Bardou,
    7. M. Daffé,
    8. J. F. Emile,
    9. B. Marchou,
    10. P. J. Cardona,
    11. et al
    . 2008. Foamy macrophages from tuberculous patients’ granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog. 4: e1000204.
    OpenUrlCrossRefPubMed
  56. ↵
    1. Lowe D. M.,
    2. P. S. Redford,
    3. R. J. Wilkinson,
    4. A. O’Garra,
    5. A. R. Martineau
    . 2012. Neutrophils in tuberculosis: friend or foe? Trends Immunol. 33: 14–25.
    OpenUrlCrossRefPubMed
  57. ↵
    1. Nandi B.,
    2. S. M. Behar
    . 2011. Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection. J. Exp. Med. 208: 2251–2262.
    OpenUrlAbstract/FREE Full Text
  58. ↵
    1. Berry M. P.,
    2. C. M. Graham,
    3. F. W. McNab,
    4. Z. Xu,
    5. S. A. Bloch,
    6. T. Oni,
    7. K. A. Wilkinson,
    8. R. Banchereau,
    9. J. Skinner,
    10. R. J. Wilkinson,
    11. et al
    . 2010. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973–977.
    OpenUrlCrossRefPubMed
  59. ↵
    1. Corleis B.,
    2. D. Korbel,
    3. R. Wilson,
    4. J. Bylund,
    5. R. Chee,
    6. U. E. Schaible
    . 2012. Escape of Mycobacterium tuberculosis from oxidative killing by neutrophils. Cell. Microbiol. 14: 1109–1121.
    OpenUrlCrossRefPubMed
  60. ↵
    1. Eum S. Y.,
    2. J. H. Kong,
    3. M. S. Hong,
    4. Y. J. Lee,
    5. J. H. Kim,
    6. S. H. Hwang,
    7. S. N. Cho,
    8. L. E. Via,
    9. C. E. Barry III.
    . 2010. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 137: 122–128.
    OpenUrlCrossRefPubMed
  61. ↵
    1. Pechkovsky D. V.,
    2. O. M. Zalutskaya,
    3. G. I. Ivanov,
    4. N. I. Misuno
    . 2000. Calprotectin (MRP8/14 protein complex) release during mycobacterial infection in vitro and in vivo. FEMS Immunol. Med. Microbiol. 29: 27–33.
    OpenUrlAbstract/FREE Full Text
  62. ↵
    1. Scapini P.,
    2. J. A. Lapinet-Vera,
    3. S. Gasperini,
    4. F. Calzetti,
    5. F. Bazzoni,
    6. M. A. Cassatella
    . 2000. The neutrophil as a cellular source of chemokines. Immunol. Rev. 177: 195–203.
    OpenUrlCrossRefPubMed
  63. ↵
    1. Kasama T.,
    2. Y. Miwa,
    3. T. Isozaki,
    4. T. Odai,
    5. M. Adachi,
    6. S. L. Kunkel
    . 2005. Neutrophil-derived cytokines: potential therapeutic targets in inflammation. Curr. Drug Targets Inflamm. Allergy 4: 273–279.
    OpenUrlCrossRefPubMed
  64. ↵
    1. Tvinnereim A. R.,
    2. S. E. Hamilton,
    3. J. T. Harty
    . 2004. Neutrophil involvement in cross-priming CD8+ T cell responses to bacterial antigens. J. Immunol. 173: 1994–2002.
    OpenUrlAbstract/FREE Full Text
  65. ↵
    1. Lin P. L.,
    2. V. Dartois,
    3. P. J. Johnston,
    4. C. Janssen,
    5. L. Via,
    6. M. B. Goodwin,
    7. E. Klein,
    8. C. E. Barry III.,
    9. J. L. Flynn
    . 2012. Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques. Proc. Natl. Acad. Sci. USA 109: 14188–14193.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Immunology: 191 (2)
The Journal of Immunology
Vol. 191, Issue 2
15 Jul 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Microenvironments in Tuberculous Granulomas Are Delineated by Distinct Populations of Macrophage Subsets and Expression of Nitric Oxide Synthase and Arginase Isoforms
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Microenvironments in Tuberculous Granulomas Are Delineated by Distinct Populations of Macrophage Subsets and Expression of Nitric Oxide Synthase and Arginase Isoforms
Joshua T. Mattila, Olabisi O. Ojo, Diane Kepka-Lenhart, Simeone Marino, Jin Hee Kim, Seok Yong Eum, Laura E. Via, Clifton E. Barry, Edwin Klein, Denise E. Kirschner, Sidney M. Morris, Philana Ling Lin, JoAnne L. Flynn
The Journal of Immunology July 15, 2013, 191 (2) 773-784; DOI: 10.4049/jimmunol.1300113

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Microenvironments in Tuberculous Granulomas Are Delineated by Distinct Populations of Macrophage Subsets and Expression of Nitric Oxide Synthase and Arginase Isoforms
Joshua T. Mattila, Olabisi O. Ojo, Diane Kepka-Lenhart, Simeone Marino, Jin Hee Kim, Seok Yong Eum, Laura E. Via, Clifton E. Barry, Edwin Klein, Denise E. Kirschner, Sidney M. Morris, Philana Ling Lin, JoAnne L. Flynn
The Journal of Immunology July 15, 2013, 191 (2) 773-784; DOI: 10.4049/jimmunol.1300113
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • IL-21/IL-21R Signaling Aggravated Respiratory Inflammation Induced by Intracellular Bacteria through Regulation of CD4+ T Cell Subset Responses
  • Accelerated Clearance and Degradation of Cell-Free HIV by Neutralizing Antibodies Occurs via FcγRIIb on Liver Sinusoidal Endothelial Cells by Endocytosis
  • The Butyrate-Producing Bacterium Clostridium butyricum Suppresses Clostridioides difficile Infection via Neutrophil- and Antimicrobial Cytokine–Dependent but GPR43/109a-Independent Mechanisms
Show more INFECTIOUS DISEASE AND HOST RESPONSE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606